Delivery Order SPE2DR25D2213-SPE2DR26F6CUD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,337.67 to AmerisourceBergen Drug Corp for the supply of Liletta 52 mg systems, with an ultimate completion date of November 24, 2025. This firm fixed-price, competitive award was issued with no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.9 million and extending through December...
- The Defense Logistics Agency awarded a $1,337.67 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Liletta 52 mg systems, with performance completing by September 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set aside and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $14,714.37 to AmerisourceBergen Drug Corp for Liletta 52 mg intrauterine contraceptive systems on September 26, 2025, with completion scheduled for October 20, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through...
- The Defense Logistics Agency awarded a $5,350.68 delivery order to AmerisourceBergen Drug Corp for Liletta 52 mg systems, a long-acting reversible contraceptive product. The delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.56 to AmerisourceBergen Drug Corp for Liletta 52 mg intrauterine contraceptive systems. The contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for...
- The Defense Logistics Agency (DLA) awarded a $8,026.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Liletta 52 mg systems, with performance in Conshohocken, Pennsylvania and completion targeted for August 27, 2025. This non-set-aside, competitively awarded contract represents a single delivery order transaction under AmerisourceBergen's existing pharmaceutical supply framework with the federal government. Liletta is a levonorgestrel-releasing intrauterine...
- The Defense Logistics Agency awarded a $4,458.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Liletta 52 mg intrauterine contraceptive systems. This non-set-aside award is scheduled for completion by October 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- Amerisourcebergen Drug Corporation, under its parent company Amerisourcebergen Corporation, has been awarded a $8,414.60 firm fixed price delivery order contract by the Defense Logistics Agency to provide 52 mg LILETTA systems. The contract has a period of performance from August 18, 2023 through September 11, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. This delivery order was issued against the Defense Logistics Agency's prime vendor...
- The Defense Logistics Agency Troop Support Medical awarded a $4,207.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for LILETTA 52 MG SYSTEMS. The delivery order was issued against an unidentified contracting vehicle to provide the contraceptive devices. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning September 1, 2023 through September 25, 2023. No set aside provisions or subcontractors were identified. The...
- Amerisourcebergen Drug Corp has received a $3,366 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562913989 LILETTA 52 MG SYSTEMS. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by the completion date of December 11, 2023. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, routinely supports DLA Troop Support Medical programs...
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6CUDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Liletta 52 mg contraceptive systems valued at $2,349.50 with a firm fixed price structure. This non-set-aside delivery order was issued on November 4, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 vehicle running through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contracting demonstrates consistent capability to fulfill competitive procurement requirements across therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles. This Liletta delivery order aligns with the company's established role as a critical vendor within the DLA's pharmaceutical supply chain supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/4/25 |